Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnuclear receptor activity

ARNT NR1I2 PPARD

3.05e-0660103GO:0004879
GeneOntologyMolecularFunctionligand-activated transcription factor activity

ARNT NR1I2 PPARD

3.21e-0661103GO:0098531
GeneOntologyMolecularFunctionaryl hydrocarbon receptor binding

ARNT ARNT2

8.11e-069102GO:0017162
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

ARNT NR1I2 PPARD ARNT2

3.56e-05417104GO:0061629
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

ARNT NR1I2 PPARD ARNT2

1.30e-04582104GO:0140297
GeneOntologyMolecularFunctionDNA-binding transcription factor activity, RNA polymerase II-specific

ARNT NR1I2 PPARD ARNT2 ZNF875

3.27e-041412105GO:0000981
GeneOntologyMolecularFunctiontranscription factor binding

ARNT NR1I2 PPARD ARNT2

3.51e-04753104GO:0008134
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

ARNT NR1I2 PPARD ARNT2 ZNF875

3.82e-041459105GO:0000977
GeneOntologyMolecularFunctionzinc ion binding

NR1I2 PPARD KMT2B ZNF875

6.66e-04891104GO:0008270
GeneOntologyMolecularFunctiontransition metal ion binding

NR1I2 PPARD KMT2B ZNF875

1.97e-031189104GO:0046914
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

ARNT NR1I2 PPARD ARNT2

2.32e-031244104GO:0000978
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

ARNT NR1I2 PPARD ARNT2

2.52e-031271104GO:0000987
GeneOntologyMolecularFunctionmethyltransferase activity

PRDM10 KMT2B

4.82e-03213102GO:0008168
GeneOntologyMolecularFunctiontransferase activity, transferring one-carbon groups

PRDM10 KMT2B

5.31e-03224102GO:0016741
GeneOntologyMolecularFunctionprotein heterodimerization activity

ARNT ARNT2

1.60e-02398102GO:0046982
GeneOntologyCellularComponentaryl hydrocarbon receptor complex

ARNT ARNT2

5.76e-068102GO:0034751
GeneOntologyCellularComponenttranscription regulator complex

PRDM10 ARNT NR1I2 ARNT2

1.20e-04596104GO:0005667
GeneOntologyCellularComponentchromatin

PRDM10 ARNT NR1I2 PPARD ARNT2

3.29e-041480105GO:0000785
MousePhenodecreased bone stiffness

PPARD SNX10

1.32e-05992MP:0013639
MousePhenoabnormal bone stiffness

PPARD SNX10

2.86e-051392MP:0013636
MousePhenoimpaired glucose tolerance

LONRF2 PPARD ARNT2 KMT2B

1.51e-0448094MP:0005293
MousePhenodecreased bone strength

PPARD SNX10

2.56e-043892MP:0004991
MousePhenodecreased bone mineral density of femur

PPARD SNX10

3.92e-044792MP:0020010
MousePhenoincreased circulating triglyceride level

PPARD KMT2B GLG1

5.03e-0426293MP:0001552
MousePhenoabnormal bone mineral density of femur

PPARD SNX10

7.05e-046392MP:0020009
MousePhenoabnormal bone strength

PPARD SNX10

9.72e-047492MP:0001542
MousePhenoabnormal bone resorption

PPARD SNX10

9.72e-047492MP:0004945
MousePhenoabnormal glucose tolerance

LONRF2 PPARD ARNT2 KMT2B

1.00e-0378794MP:0005291
DomainNuc_translocat

ARNT ARNT2

7.21e-068102IPR001067
DomainPAS_fold_3

ARNT ARNT2

6.49e-0523102IPR013655
DomainPAS_3

ARNT ARNT2

6.49e-0523102PF08447
DomainPAS-assoc_C

ARNT ARNT2

7.08e-0524102IPR000700
DomainPAS

ARNT ARNT2

7.69e-0525102PF00989
DomainPAS_fold

ARNT ARNT2

7.69e-0525102IPR013767
DomainPAC

ARNT ARNT2

8.33e-0526102IPR001610
DomainPAC

ARNT ARNT2

8.33e-0526102SM00086
DomainPAC

ARNT ARNT2

8.33e-0526102PS50113
DomainPAS

ARNT ARNT2

1.27e-0432102SM00091
DomainPAS

ARNT ARNT2

1.43e-0434102IPR000014
DomainPAS

ARNT ARNT2

1.43e-0434102PS50112
Domainzf-C4

NR1I2 PPARD

2.64e-0446102PF00105
DomainNUCLEAR_REC_DBD_1

NR1I2 PPARD

2.64e-0446102PS00031
DomainZnf_hrmn_rcpt

NR1I2 PPARD

2.64e-0446102IPR001628
DomainNuclear_hrmn_rcpt

NR1I2 PPARD

2.64e-0446102IPR001723
DomainZnF_C4

NR1I2 PPARD

2.64e-0446102SM00399
DomainNUCLEAR_REC_DBD_2

NR1I2 PPARD

2.64e-0446102PS51030
Domain-

NR1I2 PPARD

2.75e-04471021.10.565.10
DomainNucl_hrmn_rcpt_lig-bd

NR1I2 PPARD

2.87e-0448102IPR000536
DomainHormone_recep

NR1I2 PPARD

2.87e-0448102PF00104
DomainHOLI

NR1I2 PPARD

2.87e-0448102SM00430
DomainSET_dom

PRDM10 KMT2B

3.12e-0450102IPR001214
DomainSET

PRDM10 KMT2B

3.12e-0450102PS50280
Domain-

NR1I2 PPARD

4.05e-04571023.30.50.10
DomainZnf_NHR/GATA

NR1I2 PPARD

4.20e-0458102IPR013088
Domain-

ARNT ARNT2

1.47e-031091024.10.280.10
DomainHLH

ARNT ARNT2

1.53e-03111102PF00010
DomainHLH

ARNT ARNT2

1.67e-03116102SM00353
DomainBHLH

ARNT ARNT2

1.69e-03117102PS50888
DomainbHLH_dom

ARNT ARNT2

1.72e-03118102IPR011598
Domain-

LONRF2 KMT2B

2.28e-024491023.30.40.10
DomainZnf_RING/FYVE/PHD

LONRF2 KMT2B

2.38e-02459102IPR013083
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4

ARNT ARNT2

2.82e-06582MM16637
PathwayREACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING

ARNT ARNT2

4.22e-06682M27793
PathwayREACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING

ARNT ARNT2

5.91e-06782MM15528
PathwayWP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS

NR1I2 PPARD

7.88e-06882M45529
PathwayREACTOME_RNA_POLYMERASE_II_TRANSCRIPTION

ARNT NR1I2 PPARD ARNT2 KMT2B ZNF875

2.11e-05138786M734
PathwayREACTOME_GENERIC_TRANSCRIPTION_PATHWAY

ARNT NR1I2 PPARD ARNT2 KMT2B

2.31e-0576885MM14851
PathwayREACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES

ARNT ARNT2

6.47e-052282M46437
PathwayREACTOME_XENOBIOTICS

ARNT ARNT2

7.09e-052382M5372
PathwayREACTOME_XENOBIOTICS

ARNT ARNT2

8.40e-052582MM14846
PathwayREACTOME_ENDOGENOUS_STEROLS

ARNT ARNT2

8.40e-052582M11184
PathwayREACTOME_GENE_EXPRESSION_TRANSCRIPTION

ARNT NR1I2 PPARD ARNT2 KMT2B

9.23e-05102285MM15436
PathwayREACTOME_ENDOGENOUS_STEROLS

ARNT ARNT2

9.82e-052782MM14844
PathwayWP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY

NR1I2 PPARD

1.22e-043082MM15866
PathwayBIOCARTA_NUCLEARRS_PATHWAY

NR1I2 PPARD

1.47e-043382MM1448
PathwayBIOCARTA_NUCLEARRS_PATHWAY

NR1I2 PPARD

1.57e-043482M16393
PathwayWP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA

ARNT ARNT2

1.57e-043482M39771
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4

ARNT ARNT2

1.57e-043482M46422
PathwayWP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY

NR1I2 PPARD

1.66e-043582M39488
PathwayWP_NUCLEAR_RECEPTORS

NR1I2 PPARD

1.96e-043882MM15865
PathwayWP_NUCLEAR_RECEPTORS

NR1I2 PPARD

1.96e-043882M39657
PathwayREACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY

NR1I2 PPARD

3.14e-044882MM14987
PathwayREACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY

NR1I2 PPARD

3.83e-045382M8276
PathwayREACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE

ARNT ARNT2

5.58e-046482M5650
PathwayWP_NUCLEAR_RECEPTORS_METAPATHWAY

ARNT NR1I2 PPARD

5.64e-0431483M39428
PathwayREACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE

ARNT ARNT2

5.94e-046682MM14839
PathwayKEGG_PATHWAYS_IN_CANCER

ARNT PPARD ARNT2

6.24e-0432583M12868
PathwayKEGG_RENAL_CELL_CARCINOMA

ARNT ARNT2

6.68e-047082M13266
PathwayREACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS

ARNT ARNT2

1.47e-0310482M738
PathwayREACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS

ARNT ARNT2

1.49e-0310582MM14842
PathwayREACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA

ARNT ARNT2

1.88e-0311882M27316
PathwayWP_CANCER_PATHWAYS

ARNT PPARD ARNT2

2.26e-0350783M48302
PathwayWP_CIRCADIAN_RHYTHM_GENES

ARNT ARNT2

5.35e-0320182M39605
PathwayREACTOME_BIOLOGICAL_OXIDATIONS

ARNT ARNT2

6.32e-0321982MM14838
PathwayREACTOME_BIOLOGICAL_OXIDATIONS

ARNT ARNT2

6.38e-0322082M10320
PathwayREACTOME_METABOLISM_OF_LIPIDS

ARNT PPARD ARNT2

7.05e-0375783M27451
PathwayWP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES

PPARD SNX10

1.83e-0238182M48063
Pubmed

Divergent expression patterns for hypoxia-inducible factor-1beta and aryl hydrocarbon receptor nuclear transporter-2 in developing kidney.

ARNT ARNT2

7.44e-08210215466261
Pubmed

Unique and overlapping transcriptional roles of arylhydrocarbon receptor nuclear translocator (Arnt) and Arnt2 in xenobiotic and hypoxic responses.

ARNT ARNT2

7.44e-08210217023418
Pubmed

Expression of Arnt and Arnt2 mRNA in developing murine tissues.

ARNT ARNT2

2.23e-07310212502753
Pubmed

Structures of NPAS4-ARNT and NPAS4-ARNT2 heterodimers reveal new dimerization modalities in the bHLH-PAS transcription factor family.

ARNT ARNT2

2.23e-07310236343253
Pubmed

Analysis of Ah receptor-ARNT and Ah receptor-ARNT2 complexes in vitro and in cell culture.

ARNT ARNT2

2.23e-07310218096572
Pubmed

cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt).

ARNT ARNT2

2.23e-0731028657146
Pubmed

Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse.

ARNT ARNT2

7.44e-0751029545558
Pubmed

Separate necdin domains bind ARNT2 and HIF1alpha and repress transcription.

ARNT ARNT2

1.12e-06610217826745
Pubmed

Isolation and characterization of AINT: a novel ARNT interacting protein expressed during murine embryonic development.

ARNT ARNT2

1.12e-06610211025203
Pubmed

Two new members of the murine Sim gene family are transcriptional repressors and show different expression patterns during mouse embryogenesis.

ARNT ARNT2

1.12e-0661028927054
Pubmed

Identification of a novel basic helix-loop-helix-PAS factor, NXF, reveals a Sim2 competitive, positive regulatory role in dendritic-cytoskeleton modulator drebrin gene expression.

ARNT ARNT2

1.56e-06710214701734
Pubmed

MAGED1 is a novel regulator of a select subset of bHLH PAS transcription factors.

ARNT ARNT2

1.56e-06710227472814
Pubmed

NPAS1-ARNT and NPAS3-ARNT crystal structures implicate the bHLH-PAS family as multi-ligand binding transcription factors.

ARNT ARNT2

1.56e-06710227782878
Pubmed

Differential activities of murine single minded 1 (SIM1) and SIM2 on a hypoxic response element. Cross-talk between basic helix-loop-helix/per-Arnt-Sim homology transcription factors.

ARNT ARNT2

2.08e-06810211782478
Pubmed

Circadian repressors CRY1 and CRY2 broadly interact with nuclear receptors and modulate transcriptional activity.

NR1I2 PPARD

2.68e-06910228751364
Pubmed

HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature.

ARNT ARNT2

3.34e-061010216824955
Pubmed

Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt.

ARNT ARNT2

4.09e-061110211381139
Pubmed

Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development.

ARNT ARNT2

1.41e-052010220495570
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

ARNT2 KMT2B GLG1

2.67e-0521410322199357
Pubmed

Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes.

NR1I2 ZNF875

3.22e-053010225678563
Pubmed

Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.

NR1I2 PPARD

6.07e-054110219878569
Pubmed

An atlas of combinatorial transcriptional regulation in mouse and man.

ARNT NR1I2 PPARD ARNT2

7.47e-0587710420211142
Pubmed

A census of human transcription factors: function, expression and evolution.

ARNT NR1I2 PPARD ARNT2

8.55e-0590810419274049
Pubmed

Analysis of BCL6-interacting proteins by tandem mass spectrometry.

ARNT2 KMT2B

1.39e-046210216147992
Pubmed

Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.

ARNT ARNT2

1.58e-046610223275444
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ARNT2 KMT2B

2.75e-048710212465718
InteractionNPAS4 interactions

ARNT ARNT2

3.32e-066102int:NPAS4
InteractionSIM1 interactions

ARNT ARNT2

6.20e-068102int:SIM1
InteractionNPAS3 interactions

ARNT ARNT2

7.96e-069102int:NPAS3
InteractionNCOR1 interactions

ARNT NR1I2 PPARD ARNT2

2.00e-05363104int:NCOR1
InteractionNCOA2 interactions

ARNT NR1I2 PPARD

3.88e-05141103int:NCOA2
InteractionNCOA1 interactions

ARNT NR1I2 PPARD

4.31e-05146103int:NCOA1
InteractionNR6A1 interactions

ARNT ARNT2

6.08e-0524102int:NR6A1
InteractionSIM2 interactions

ARNT ARNT2

6.61e-0525102int:SIM2
InteractionNCOA3 interactions

NR1I2 PPARD ARNT2

1.53e-04224103int:NCOA3
InteractionBCL6 interactions

PPARD ARNT2 KMT2B

1.64e-04229103int:BCL6
InteractionNPAS2 interactions

ARNT ARNT2

1.89e-0442102int:NPAS2
InteractionRXRG interactions

NR1I2 PPARD

2.37e-0447102int:RXRG
InteractionNCOR2 interactions

ARNT NR1I2 PPARD

2.49e-04264103int:NCOR2
InteractionHNF4A interactions

ARNT NR1I2 KMT2B

2.81e-04275103int:HNF4A
InteractionTFEB interactions

ARNT ARNT2

2.90e-0452102int:TFEB
InteractionTCF7L2 interactions

ARNT PPARD ARNT2

3.12e-04285103int:TCF7L2
InteractionLDB2 interactions

ARNT ARNT2

3.36e-0456102int:LDB2
InteractionRXRB interactions

NR1I2 PPARD

4.67e-0466102int:RXRB
InteractionNR4A3 interactions

ARNT ARNT2

5.11e-0469102int:NR4A3
InteractionPPARGC1A interactions

NR1I2 PPARD

7.21e-0482102int:PPARGC1A
InteractionNR0B2 interactions

NR1I2 PPARD

7.38e-0483102int:NR0B2
InteractionREL interactions

PRDM10 ARNT2 GLG1

7.68e-04388103int:REL
InteractionTFAP2D interactions

ARNT ARNT2

8.48e-0489102int:TFAP2D
InteractionABT1 interactions

PRDM10 ARNT ARNT2

9.87e-04423103int:ABT1
InteractionARNT2 interactions

ARNT ARNT2

1.11e-03102102int:ARNT2
InteractionAJUBA interactions

LONRF2 ARNT2

1.13e-03103102int:AJUBA
InteractionYAP1 interactions

ARNT NR1I2 ARNT2 KMT2B

1.40e-031095104int:YAP1
InteractionRELA interactions

ARNT PPARD GLG1

1.47e-03485103int:RELA
InteractionMTDH interactions

ARNT2 KMT2B GLG1

1.65e-03505103int:MTDH
InteractionAHR interactions

ARNT ARNT2

1.85e-03132102int:AHR
InteractionTADA3 interactions

NR1I2 KMT2B

2.11e-03141102int:TADA3
InteractionMAPK7 interactions

NR1I2 GLG1

2.17e-03143102int:MAPK7
InteractionNCOA6 interactions

NR1I2 KMT2B

2.23e-03145102int:NCOA6
InteractionTACC3 interactions

ARNT ARNT2

2.32e-03148102int:TACC3
InteractionTCF12 interactions

ARNT ARNT2

2.32e-03148102int:TCF12
InteractionSMAD9 interactions

ARNT PPARD

2.48e-03153102int:SMAD9
InteractionSELENBP1 interactions

ARNT KMT2B

2.48e-03153102int:SELENBP1
InteractionSTK16 interactions

ARNT2 GLG1

2.54e-03155102int:STK16
CytobandEnsembl 112 genes in cytogenetic band chr19q13

KMT2B ZNF875

2.64e-021192102chr19q13
GeneFamilyNuclear hormone receptors

NR1I2 PPARD

2.56e-04499271
GeneFamilyBasic helix-loop-helix proteins

ARNT ARNT2

1.28e-0311092420
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NR1I2 ARNT2

3.45e-04126102feedea978d76de326c14da5149e57d0d767271b9
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NR1I2 ARNT2

3.45e-041261026311cc64320db7e24a09065ebdf054f5f551b182
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LONRF2 ARNT2

4.69e-04147102989a48bda98fbff398985397a6b1189a4cbc80e7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LONRF2 ARNT2

4.69e-04147102f6681c849c4c06154548bd29a094f202d1c946c2
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-liver_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PRDM10 PPARD

5.14e-04154102acfbde0fbc09fd69af62a81f8f63e14e36dd1ae0
ToppCellTCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS-5|TCGA-Testes / Sample_Type by Project: Shred V9

ZNF875 SNX10

5.76e-0416310280bc3732afd8501938753120b8403098c7c5e928
ToppCellTCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS|TCGA-Testes / Sample_Type by Project: Shred V9

ZNF875 SNX10

5.76e-0416310267551fefe22bd5b8178fa248fed2a6c17b19fb0f
ToppCellPND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PRDM10 SNX10

6.12e-0416810252fd65024af8683db11d931f7563cbe8eb815d1c
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

PRDM10 ZNF875

6.19e-04169102b66ffc2b2b6bfcc3a6e639d9d31d3de95f4a94e1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

6.41e-041721020c2d0bb767e5ce089b42ad49e8b303a103de2d5c
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

6.41e-04172102eeed177a03c116e9815a8e086d24efc9643b16a4
ToppCellCOVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type

LONRF2 ARNT2

6.71e-0417610245028197364c64e93e3ffe86aff773d47a477d49
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LONRF2 SNX10

6.94e-04179102228d12ed1c8dc92aefbcea4aaf7d108783c22be0
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass

LONRF2 ARNT2

6.94e-041791025f7e6670a0e906a0a5bc75735408361d88e78fa2
ToppCell3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LONRF2 ARNT2

7.01e-04180102d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab
ToppCell5'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARNT2 SNX10

7.09e-041811024d7d367f4ed390908888391335c714a22b5a75c4
ToppCell3'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARNT2 SNX10

7.17e-04182102b4f347fb684f6840c166d7473f3f56389f69c14b
ToppCellCOVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type

LONRF2 ARNT2

7.25e-041831025c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.65e-04188102eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.65e-04188102bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCellCOVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

ARNT2 SNX10

7.65e-041881021d56cd409793f05cca20757ab26e91f1a1ee67b5
ToppCellCOVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type

ARNT2 SNX10

7.65e-04188102df1fd0819d301679f3c9ea404e942e39095912eb
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.73e-041891027eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.73e-041891028c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellRA-14._Fibroblast_III|RA / Chamber and Cluster_Paper

LONRF2 PPARD

7.73e-0418910246e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.73e-04189102975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCellRA-14._Fibroblast_III|World / Chamber and Cluster_Paper

LONRF2 PPARD

7.73e-04189102b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.73e-041891025d902a4660a27548764bf04c6de152b565da835c
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.73e-04189102977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.81e-04190102b94df372bc08de11585b2467dba8c8fffff5cd92
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.81e-04190102cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARNT2 SNX10

7.81e-04190102e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCellCOVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class

ARNT2 SNX10

7.97e-04192102be9d5685fa03563322f147a4b38ed31e4da59487
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor

PPARD SNX10

8.22e-0419510255e25f702af19146a161861cfd15f40bbda1dc35
ToppCellfrontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LONRF2 SNX10

8.30e-04196102de7d10da862f98894ce47244fbc992f4a12d63bb
ToppCellAdult-Immune|Adult / Lineage, Cell type, age group and donor

PPARD SNX10

8.47e-041981029bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCellTracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

PRDM10 SNX10

8.56e-041991024e0b73d88b1345ec63a9e5629762341e75beb47f
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

PPARD SNX10

8.64e-04200102cc8368665bc6bb7c4f39632ccff07ceaa98a7b65
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

PPARD SNX10

8.64e-042001020d76b006d8e8b32174e65e400acd0674354b962c
Drug1,1-dimethylbiguanide hydrochloride; Down 200; 1000uM; MCF7; HG-U133A

ARNT NR1I2 ARNT2 KMT2B GLG1

1.18e-081991054_DN
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A

ARNT PPARD KMT2B GLG1

1.01e-061931044322_UP
Drugbis(hexamethylene)triamine

ARNT PPARD ARNT2

1.67e-0656103CID000008924
DrugDMEs

ARNT NR1I2 ARNT2

3.43e-0671103CID003038361
Drugmonoisononylphthalate

NR1I2 PPARD

6.24e-069102ctd:C471400
Drug11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol

ARNT ARNT2

6.24e-069102ctd:C541120
Drugmono-benzyl phthalate

NR1I2 PPARD

7.80e-0610102ctd:C103325
Drug2-acetamidoacrylate

ARNT ARNT2

9.53e-0611102CID000079482
Drugbutylbenzyl phthalate

ARNT NR1I2 ARNT2

1.22e-05108103ctd:C027561
DrugE-guggulsterone

ARNT NR1I2 PPARD

1.22e-05108103CID006439929
Drug1,3-dinitropyrene

ARNT ARNT2

1.82e-0515102CID000053230
Drugcyprodinil

ARNT NR1I2

2.35e-0517102ctd:C108338
Drug2-nitrofluoranthene

ARNT ARNT2

2.65e-0518102CID000025760
DrugTBHQ

ARNT NR1I2 ARNT2

2.70e-05141103CID000016043
DrugHAHs

ARNT ARNT2

2.96e-0519102CID003035605
Drugcobalt(II) chloride

ARNT PPARD ARNT2

3.00e-05146103CID000024288
Drug6-nitrochrysene

ARNT ARNT2

3.99e-0522102CID000024121
Drughexachlorodibenzo-p-dioxin

ARNT ARNT2

4.77e-0524102CID000038251
DrugBromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; HL60; HG-U133A

ARNT PPARD GLG1

4.97e-051731032007_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

PRDM10 ARNT KMT2B

5.06e-051741035745_DN
Drug1-aminopyrene

ARNT ARNT2

5.18e-0525102CID000015352
DrugFelodipine

NR1I2 PPARD

5.61e-0526102ctd:D015736
Drug3-nitrofluoranthene

ARNT ARNT2

5.61e-0526102CID000013462
Drug(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; PC3; HT_HG-U133A

PRDM10 PPARD ARNT2

5.79e-051821036663_UP
Drugmonobutyl phthalate

NR1I2 PPARD

6.06e-0527102CID000008575
DrugPeCDD

ARNT ARNT2

6.06e-0527102CID000038439
Drugandrostenol

NR1I2 PPARD

6.06e-0527102CID000101989
DrugProgesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A

ARNT PPARD GLG1

6.17e-051861032426_DN
Drugsulforaphane

ARNT NR1I2 ARNT2

6.47e-05189103CID000005350
DrugMCDF

ARNT ARNT2

6.52e-0528102CID000114900
DrugDiphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A

ARNT KMT2B GLG1

6.89e-051931031830_UP
DrugFluconazole

ARNT NR1I2

7.00e-0529102ctd:D015725
DrugFlunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A

PRDM10 ARNT PPARD

7.10e-051951033828_UP
DrugTrimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; HL60; HT_HG-U133A

PPARD KMT2B GLG1

7.21e-051961032736_DN
Drugcopper(II) sulfate pentahydrate; Down 200; 100uM; MCF7; HG-U133A

ARNT NR1I2 GLG1

7.32e-05197103438_DN
DrugTetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; PC3; HT_HG-U133A

ARNT PPARD ARNT2

7.32e-051971034078_UP
DrugTTNPB; Up 200; 0.1uM; PC3; HG-U133A

NR1I2 KMT2B GLG1

7.32e-05197103451_UP
DrugEsculetin [305-01-1]; Up 200; 22.4uM; HL60; HT_HG-U133A

PRDM10 PPARD GLG1

7.32e-051971033120_UP
DrugMemantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; HL60; HT_HG-U133A

PRDM10 ARNT GLG1

7.32e-051971032934_DN
DrugPirlindole mesylate [60762-57-4]; Up 200; 12.4uM; HL60; HT_HG-U133A

NR1I2 PPARD GLG1

7.43e-051981033140_UP
DrugSolasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A

PPARD KMT2B GLG1

7.43e-051981033749_DN
DrugOxybenzone [131-57-7]; Down 200; 17.6uM; HL60; HT_HG-U133A

PRDM10 PPARD GLG1

7.43e-051981033092_DN
DrugMetampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; PC3; HT_HG-U133A

ARNT PPARD GLG1

7.43e-051981032123_DN
Drugestradiol, USP; Down 200; 0.1uM; MCF7; HG-U133A

NR1I2 KMT2B GLG1

7.54e-05199103365_DN
Drugbeta-naphthoflavone

ARNT NR1I2 ARNT2

7.66e-05200103CID000002361
Drug1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A

ARNT NR1I2 GLG1

7.66e-052001031_DN
DrugAGN 193109

ARNT ARNT2

8.02e-0531102CID000177238
DrugItraconazole

ARNT NR1I2

8.55e-0532102ctd:D017964
DrugTCDF

ARNT ARNT2

9.67e-0534102CID000039929
Drugp-dioxin

ARNT ARNT2

1.15e-0437102CID000078968
DrugAR E

ARNT NR1I2 ARNT2

1.16e-04230103CID004369394
Drugperfluorohexanoic acid

NR1I2 PPARD

1.21e-0438102ctd:C479228
DrugAC1L3U0V

ARNT ARNT2

1.34e-0440102CID000122124
Drug2d3z

ARNT ARNT2

1.41e-0441102CID009543495
Drugtirapazamine

ARNT ARNT2

1.78e-0446102CID000033776
DrugRI-331

ARNT ARNT2

1.86e-0447102CID000160754
DrugDB04724

ARNT ARNT2

1.94e-0448102CID005288688
Drugfenofibric acid

NR1I2 PPARD

2.02e-0449102CID000064929
DrugMEHP

NR1I2 PPARD

2.10e-0450102CID000020393
DrugLY171883

NR1I2 PPARD

2.19e-0451102CID000003969
DrugAhR antagonist

ARNT NR1I2

2.28e-0452102CID003091786
Drug3-methylquercetin

NR1I2 PPARD

2.36e-0453102ctd:C047368
DrugHCG 004

NR1I2 PPARD

2.45e-0454102CID000064928
Drug27-hydroxycholesterol

NR1I2 PPARD

2.64e-0456102CID000099470
Drugbromazepam

NR1I2 GLG1

2.74e-0457102CID000002441
Drug6-formylindolo(3,2-b)carbazole

ARNT NR1I2

3.03e-0460102ctd:C111855
Drug2-ketobenzothiazole 23

NR1I2 PPARD

3.03e-0460102CID003348131
Drugdibenzofurans

ARNT ARNT2

3.67e-0466102CID000000568
Drugdioxin

ARNT NR1I2 ARNT2

3.89e-04347103CID000015625
DrugNOR-1

LONRF2 PPARD

4.13e-0470102CID006399012
DiseaseFatty Liver

NR1I2 PPARD

3.90e-0488102C0015695
DiseaseSteatohepatitis

NR1I2 PPARD

3.90e-0488102C2711227
Diseasemetabolic syndrome

ARNT SNX10

1.98e-03200102EFO_0000195
DiseaseObesity

NR1I2 PPARD

2.08e-03205102C0028754
Diseasemelanoma

ARNT PPARD

3.03e-03248102C0025202
Diseasesexual dimorphism measurement

PPARD KMT2B SNX10

5.17e-031106103EFO_0021796
Diseaseserum non-albumin protein measurement

LONRF2 ARNT

6.29e-03361102EFO_0004568
DiseaseHepatitis, Toxic

ARNT NR1I2

7.83e-03404102C0019193
DiseaseHepatitis, Drug-Induced

ARNT NR1I2

7.83e-03404102C1262760
DiseaseChemically-Induced Liver Toxicity

ARNT NR1I2

7.83e-03404102C4279912
DiseaseDrug-Induced Liver Disease

ARNT NR1I2

7.83e-03404102C0860207
DiseaseDrug-Induced Acute Liver Injury

ARNT NR1I2

7.83e-03404102C3658290
DiseaseChemical and Drug Induced Liver Injury

ARNT NR1I2

7.83e-03404102C4277682
Diseasecarotid artery intima media thickness

PRDM10 ARNT2

9.63e-03450102EFO_0007117
DiseaseColorectal Carcinoma

LONRF2 ARNT

2.24e-02702102C0009402

Protein segments in the cluster

PeptideGeneStartEntry
CMGSRRSFICRMRCG

ARNT

256

P27540
MGSRRSFICRMRCGN

ARNT2

231

Q9HBZ2
MRMARCGHCRGCLRV

KMT2B

961

Q9UMN6
RRCMETGTKRFGMCL

LONRF2

566

Q1L5Z9
TFKCRLCMMGFRRRG

PRDM10

726

Q9NQV6
MTCEGCKGFFRRAMK

NR1I2

56

O75469
MAACGRVRRMFRLSA

GLG1

1

Q92896
CEGCKGFFRRTIRMK

PPARD

91

Q03181
MCFTMKTSCVRRRYR

SNX10

41

Q9Y5X0
KPFMCRECGRRFRQK

ZNF875

551

P10072